期刊文献+

肾脏病学的新创意:“肾脏疾病:改善全球预后”(KDIGO) 被引量:19

Innovation in nephrology: "Kidney Disease: Improving Global Outcome" (KDIGO)
原文传递
导出
摘要 慢性肾脏病(CKD)是世界范围的医疗和公共卫生问题,并开始呈现流行性的特点.美国肾脏数据系统(USRDS)的数据提示,终末期肾衰的发病率呈上升趋势,因此对于这一问题的重视日益增加.根据近期USRDS登记系统提供的资料,世界范围内需要肾脏替代治疗(RRT)的终末期肾病(ESRD)患者数目持续上升,其中我国台湾、美国和日本最多(254~365人/100万人)[1].卡塔尔和巴斯克地区的儿童患病率最高,分别为33.7人/100万人和22.7人/100万人;在大于等于20岁患者中患病率最高的是卡塔尔、美国和台湾.在欧洲,德国的患病率最高,2000年为175人/100万人.在RRT仍在发展中的东欧,报道的患病率低于西欧[2].
机构地区 [
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2005年第12期757-760,共4页 Chinese Journal of Nephrology
  • 相关文献

参考文献41

  • 1USRDS Annual Report.2004.
  • 2Rutkowski B.Changing pattern of end-stage renal disease in central and eastern Europe.Nephrol Dial Transplant,2000,15:156-160.
  • 3Moeller S,Gioberge S,Brown G.ESRD patients in 2001:global overview of patients treatment modalities and development trends.Nephrol Dial Transplant,2002,17:2071 -2076.
  • 4中华医学会肾脏病分会透析移植登记工作组,钱家麒,张伟明,徐筱琪.1999年度全国透析移植登记报告[J].中华肾脏病杂志,2001,17(2):77-78. 被引量:441
  • 5Van Dijk PC,Jager KJ,de Charro F,et al.Renal replacement therapy in Europe:the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries.Nephrol Dial Transplant,2001,16:1120-1129.
  • 6Canadian Organ Replacement Register 2000 Report.2000.
  • 7全国血压抽样调查协作组.中国高血压的患病率、知晓率及治疗和控制状况:1991年抽样调查结果[J].高血压杂志,1995,3(A01):14-18. 被引量:199
  • 8向红丁,吴纬,刘灿群,李康,冯晋光,张英廷,王凤歧,阎胜利,王春俭,徐跃初,徐端衍,傅祖植,刘尊永,李天麟,白锦,富振英,王克安.1996年全国糖尿病流行病学特点基线调查报告[J].中国糖尿病杂志,1998,6(3):131-133. 被引量:396
  • 9Collins A J,Li S,Gillbertson DT,et al.Chronic kidney disease and cardiovascular disease in the medicare population.Kidney Int,2003,Suppl:S24-S31.
  • 10Levin A.Cardiac disease in chronic kidney disease:current understandings and opportunities for change.Blood Purif,2004,22:21-27.

二级参考文献26

  • 1向红丁,冯晋光,颜纯,高红军,黄敬生,杨迎燕,商维霞.我国东北一个县自然人群糖尿病流行病学调查[J].中国糖尿病杂志,1995,3(2):85-88. 被引量:36
  • 2侯凡凡.慢性肾脏病的心血管并发症[J].中华心血管病杂志,2004,32:16-16.
  • 3何长民 张训 见:何长民 张训主编.前言[A].见:何长民,张训主编.肾脏替代治疗学[C].上海:上海科学技术文献出版社,1999.2..
  • 4Locatelli F, Pozzoni P, Tentori F, et al. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant, 2003,18 Suppl 7:2-9.
  • 5Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 2002,13:745-753.
  • 6Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003,41:47-55.
  • 7Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int, 1995,47:186-192.
  • 8Sarnak MJ, Levey AS, Schoolwerth AC,et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation, 2003,108:2154-2169.
  • 9Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 Study. Kidney Int, 2003,63:1462-1467.
  • 10Wong JS, Rort FK, Hulbert-Shearon TE, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int, 1999,55:2515-2523.

共引文献1211

同被引文献170

引证文献19

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部